Effects of intake of royal jelly in type 2 diabetic patients
Not Applicable
- Conditions
- DIABETES MELLITUS.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT138905102709N8
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
confirmed diabetes type 2 based on physicians diagnosis, being volunteer or willingness to attend, no history of cardiovascular, liver or kidney diseases, not receiving insulin prior to 3 months before the trial, age between 20-65 years old, HbA1c 6-8%, no allergy to honey or its products, BMI between 20-30, duration of type 2 diabetes mellitus for 5 -10 years, no history of smoking and alcohol drinking
Exclusion criteria: cholesterol >=240mg/dl, TG>=400mg/dl, incomplete consumption of royal jelly, creation of allergy during the study period, using of any kind of food supplements, pregnancy, lactation, using of oral contraceptive pills, changing medication dosage
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fast blood sugar. Timepoint: Before and after the intervention. Method of measurement: Enzymatic,Glucose oxidase.;Serum Insulin Level. Timepoint: Before and after the intervention. Method of measurement: fast serum insulin level,IRMA method.;HOMA-R. Timepoint: Before and after the intervention. Method of measurement: HOMA-IR=Glucose ? Insulin/405,Calculating.;HbA1c. Timepoint: Before and after the intervention. Method of measurement: fast HbA1c serum level,Chromatography.;APO-A1. Timepoint: Before and after the intervention. Method of measurement: fast APO-A1 serum level,Immunoturbidimetry.;APO-B. Timepoint: before and after intervention. Method of measurement: fast APO-B serum level,Immunoturbidimetry.;Blood pressure. Timepoint: at the baseline, at the middle and the end of the study. Method of measurement: blood pressure,sphygmomanometer.
- Secondary Outcome Measures
Name Time Method